Notably, a downregulation of DDB2 was already found in advanced oral/head and neck squamous cell carcinoma (HNSCC) and in colon cancer tissues compared to normal tissues and patients with HNSCC harboring low DDB2 mRNA expression level were associated with a shorter overall survival (14, 15). Here, DDB2 is linked to head and neck squamous cell carcinoma.